In vitro antitumor activity evaluation of some 1,2,4-triazine derivatives bearing piperazine amide moiety against breast cancer cells

Bioorg Med Chem. 2014 Nov 15;22(22):6313-23. doi: 10.1016/j.bmc.2014.10.002. Epub 2014 Oct 13.

Abstract

A series of 1,2,4-triazine derivatives bearing piperazine amide moiety has been synthesized and investigated for their potential anticancer activities. 1-[4-(5,6-Bis(4-subtituted phenyl)-1,2,4-triazin-3-yl)piperazin-1-yl]-2-[4-(3-substituted phenyl)piperazin-1-yl]ethanone derivative (1-32) compounds were synthesized by a four step synthetic procedure. The activity studies were evaluated using XTT method, BrdU method and flow cytometric analysis on MCF-7 breast cancer cells and NIH/3T3 (mouse embryonic fibroblast cells) healthy cells. Compounds 5 with 3-chlorophenyl and compound 7 with 4-chlorophenyl substitutions were found to be promising antiproliferative agents comparing with an effective anticancer drug, cisplatin.

Keywords: 1,2,4-Triazine; Antiproliferative activity; Apoptosis; Breast cancer; Piperazine amide; XTT method.

MeSH terms

  • Amides / chemistry*
  • Animals
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / toxicity
  • Apoptosis / drug effects
  • Breast Neoplasms
  • Cisplatin / toxicity
  • Female
  • Humans
  • MCF-7 Cells
  • Mice
  • NIH 3T3 Cells
  • Piperazine
  • Piperazines / chemistry*
  • Triazines / chemical synthesis
  • Triazines / chemistry*
  • Triazines / toxicity

Substances

  • Amides
  • Antineoplastic Agents
  • Piperazines
  • Triazines
  • Piperazine
  • 1,2,4-triazine
  • Cisplatin